[29P-pm] Pathophysiology

[29P-pm484S] Impact of miR-223p-mediated downregulation of arylacetamide deacetylase on drug hydrolysis and lipid accumulation

○Yoshiyuki Sakai¹, Tatsuki Fukami^1,2, Shinsaku Tokumitsu¹, Shimon Nakashima¹, Masataka Nakano^1,2, Yuichiro Higuchi³, Shotaro Uehara³, Nao Yoneda³, Hiroshi Suemizu³, Miki Nakajima^1,2 (1. Faculty of Pharmaceutical Sciences, Kanazawa University, 2. WPI Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, 3. Liver Engineering Laboratory, Department of Applied Research for Laboratory Animals, Center Institute for Experimental Animals, Kanagawa)